|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
0.113 -0.004 (-3.419%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -9.437% | -8.258% | 1.088% | -14.183% | 0.273% |
| ROAE (%) | -11.187% | -10.043% | 1.528% | -21.702% | 0.366% |
| Return on Capital Employed (%) | -11.466% | -10.692% | 1.486% | -24.833% | 0.333% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 36.405% | 44.162% | 43.615% | 43.115% | 46.471% |
| EBITDA Margin (%) | -24.542% | -18.366% | 13.195% | -70.458% | 21.685% |
| Pre-tax Profit Margin (%) | -33.746% | -26.263% | 3.253% | -89.276% | 5.344% |
| Net Profit Margin (%) | -33.554% | -25.008% | 4.018% | -64.396% | 1.125% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 3.980 X | 3.714 X | 3.471 X | 1.757 X | 2.198 X |
| Quick Ratio (X) | 3.741 X | 3.554 X | 3.332 X | 1.688 X | 2.136 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 15.521% | 17.601% | 18.726% | 38.652% | 29.700% |
| Total Debt / Total Assets (%) | 2.854% | 2.057% | 2.975% | 4.152% | 3.323% |
| Net Debt / Total Assets (%) | -20.381% | -26.847% | -25.795% | -18.444% | -23.368% |
| Total Debt / Shareholders' Funds (%) | 3.338% | 2.470% | 3.658% | 6.567% | 4.958% |
| Long Term Debt / Shareholders' Funds (%) | 2.002% | 1.494% | 2.069% | 5.122% | 3.921% |
| Net Debt / Shareholders' Funds (%) | -23.834% | -32.230% | -31.723% | -29.172% | -34.861% |
| Net Cash / (Debt) ($) | 96.140M | 138.960M | 156.079M | 141.578M | 226.983M |
| Net Cash / (Debt) per share ($) | 0.019 | 0.028 | 0.031 | 0.028 | 0.045 |
| Total Debt / Capital Employed (%) | 3.307% | 2.456% | 3.581% | 6.418% | 4.551% |
| Interest Coverage Ratio (X) | N/A | N/A | 2.647 X | N/A | 2.369 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 59.562 Day | 48.697 Day | 57.507 Day | 58.603 Day | 37.275 Day |
| Receivables Turnover (Day) | 246.060 Day | 208.825 Day | 178.354 Day | 141.018 Day | 135.365 Day |
| Payables Turnover (Day) | 15.596 Day | 31.827 Day | 71.991 Day | 87.794 Day | 43.974 Day |
| Remarks: | Real time quote last updated: 27/03/2026 10:48 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -46,678 |
| %Change | 0.697% |
| EPS / (LPS) | HKD -0.009 |
| NBV Per Share ($) | HKD 0.080 |